Skip to main content
. 2021 Sep;11(3):302–309. doi: 10.2991/jegh.k.210524.001

Table 2.

Benchmarking of device-associated healthcare-acquired infection rates in our ICU (2008 and current reports) against the reports of International Nosocomial Infection Control Consortium (INICC) in a medical/surgical ICU

DUR/DA-HAI rate INICCa (2007–2012) Leblebicioglu et al.b (2003–2012) Aly et al.c (2004–2005) This reportd (2018–2019)
CL, DUR/ 0.54 (0.54–0.54) 0.65 (0.65–0.65) 0.88 0.80 (0.8–0.84)
  CLABSI rate 4.9 (4.8–5.1) 8.5 (8.0–9.1) 5.5 6.70 (4.7–8.8)
MV, DUR/ 0.36 (0.36–0.36) 0.54 (0.54–0.54) 0.78 0.98 (0.97–0.99)
  VAP rate 16.5 (16.1–16.8) 22.3 (21.3–23.2) 9.1 2.10 (0.94–3.2)
UC, DUR/ 0.62 (0.62–0.62) 0.88 (0.88–0.88) 0.95 0.73 (0.71–0.76)
  CAUTI rate 5.3 (5.2–5.8) 7.9 (7.5–8.4) 2.3 4.30 (2.8–5.7)
a

Worldwide report [41].

b

Report from Turkey as part of the INICC [36].

c

2008 report from our ICU [25].

d

Pooled mean and 95% confidence intervals.